Aspire Biopharma Holdings (ASBP) EPS (Diluted) (2021 - 2026)
Powered by 
Analysis
Aspire Biopharma Holdings (ASBP) EPS (Diluted) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 208.48 Bn | 194.49 Bn | 7.24 Bn | 4.37 |
| 2 | Gilead Sciences | 186.29 Bn | 183.02 Bn | 6.22 Bn | -8.44 |
| 3 | Vertex Pharmaceuticals | 128.79 Bn | 120.93 Bn | 2.84 Bn | 4.31 |
| 4 | Regeneron Pharmaceuticals | 80.66 Bn | 72.67 Bn | 3.93 Bn | 12.23 |
| 5 | Moderna | 61.46 Bn | 56.32 Bn | 52.00 Mn | -1.96 |
| 6 | Argenx Se | 61.28 Bn | 56.10 Bn | 1.37 Bn | 7.15 |
| 7 | Alnylam Pharmaceuticals | 32.04 Bn | 28.73 Bn | 992.69 Mn | 1.19 |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn | 0.66 |
| 9 | Roivant Sciences | 28.74 Bn | 29.43 Bn | 1.16 Mn | -0.40 |
| 10 | Aspire Biopharma Holdings | 64.13 Mn | 51.96 Mn | -30,086.00 | -1.22 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.22 |
| Mar 31, 2026 | -20.57 |
| Dec 31, 2025 | -5.41 |
| Sep 30, 2025 | -2.12 |
| Jun 30, 2025 | -1.61 |
| Mar 31, 2025 | -16.83 |
| Dec 31, 2024 | -3.24 |
| Sep 30, 2024 | -1.11 |
| Jun 30, 2024 | -2.85 |
| Mar 31, 2024 | -10.98 |
| Dec 31, 2023 | -0.62 |
| Sep 30, 2023 | -0.31 |
| Jun 30, 2023 | 15.62 |
| Mar 31, 2023 | 12.79 |
| Dec 31, 2022 | 9.66 |
| Sep 30, 2022 | 4.80 |
| Jun 30, 2022 | 0.54 |
| Mar 31, 2022 | -0.16 |
| Dec 31, 2021 | 0.00 |
| Sep 30, 2021 | -0.10 |